Karyopharm Therapeutics dividends

KPTI dividends

Ex-dividendAmountYieldPay date

This company doesn't provide dividends.

Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases.

Karyopharm Therapeutics

Industry: Biotechnology
Sector: Healthcare
Headquarters: Newton Centre, Newton, Massachusetts, United States





Learning section - What Is a Dividend?

A dividend is the distribution of reward from a portion of the company's earnings and is paid to a class of its shareholders. Dividends are decided and managed by the company's board of directors, though they must be approved by the shareholders through their voting rights